Year: 2025

Second Drill to Begin Shortly VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) — Pecoy Copper Corp. (“Pecoy Copper” or the “Company”) (TSXV: PCU; FSE: D5E; OTCQB: PCUUF) is pleased to announce that the first drill has officially began turning at the Company’s flagship Pecoy Project. A second drill is expected to commence operations within the next few days, with additional drill rigs to mobilize in 2026. This significant milestone marks the beginning of the first drilling exploration program since 2016 at the flagship Pecoy Copper-Gold-Molybdenum-Silver Project (“Pecoy” or the “Project”) located in southern Peru. Drill Program OverviewThe initial drill hole has commenced in the South Breccia zone. (see Figure 1) A second drill rig is mobilizing to target the Center Pit zone. (see Figure 1) Multiple drill rigs will...

MONTRÉAL, Dec. 16, 2025 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation”) announces that the five (5) nominees listed in the management information circular dated November 4, 2025, were elected as directors of Falco. The Corporation also announces that Mr. Alexander Dann has been appointed as Chair of the Board, effective immediately, succeeding Mr. Mario Caron, who will continue to serve as lead director. Mr. Dann has served on the Board since 2021 and is a member of the Corporation’s audit committee. Members of the Board and the management team of Falco thank Mr. Caron for his leadership and guidance as Chair and are pleased that Falco will continue to benefit from his contributions as a member of the Board. Appointment and Remuneration of Auditor PricewaterhouseCoopers, LLP, Chartered Professional...

SAN FRANCISCO and BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) — SandboxAQ and MapLight Therapeutics, Inc. (Nasdaq: MPLT) announced today that the companies have entered into a strategic collaboration to discover and develop potential first-in-class therapies targeting a novel G protein-coupled receptor (GPCR) for the treatment of central nervous system (CNS) disorders. Under the terms of the agreement, SandboxAQ received an upfront payment and will be eligible to receive additional preclinical, development, regulatory, and commercial milestone payments of up to $200 million in aggregate. The companies will jointly conduct preclinical research activities and MapLight will have exclusive rights for potential clinical development and commercialization of collaboration compounds. “We are excited to advance research efforts for this novel...

PETAH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) (“Gilat” or the “Company”), a worldwide leader in satellite networking technology, solutions and services, announced today that, following the approval of its Board of Directors, it has received and accepted commitments from Israeli institutional and accredited investors (as defined under Israel’s Securities Law, 5728-1968) (the “Investors”), to participate in a private placement (the “Private Placement”) of Ordinary Shares of the Company (“Ordinary Shares”). The Company is expected to issue and sell to the Investors an aggregate of 8,888,889 Ordinary Shares (the “Shares”), for a purchase price of US$11.25 per Share, which represents an approximately 7.9% discount to the 10-day Volume Weighted Average Price (VWAP)1. The...

Beijing, Dec. 16, 2025 (GLOBE NEWSWIRE) — Token Cat Limited (Nasdaq: TC) (the “Company” or “TC”) today announced that it has entered into a master service agreement with Better Now New York Inc. (“Better Now”), pursuant to which the two parties will collaborate on the development and operation of an artificial intelligence data center project. This cooperation marks an important step in the Company’s expansion of its overseas data center resource footprint. Under the terms of the agreement, the parties plan to advance an AI data center project in the United States based on approximately 30 megawatts (MW) of power capacity, to be implemented on a phased basis. As a key condition for the initial stage of the project, TC currently has access to approximately 12 MW of available power capacity in the United States, which is expected...

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a pre-existing royalty interest in Nuvalent’s neladalkib and zidesamtinib from an undisclosed third party for up to $315 million. Neladalkib and zidesamtinib are next-generation tyrosine kinase inhibitors (TKIs). Neladalkib is in development for patients with ALK mutation-positive non-small cell lung cancer (NSCLC) and zidesamtinib is in development for ROS1 mutation-positive NSCLC. Both therapies are designed to deliver a best-in-class combination of efficacy and tolerability. In November 2025, Nuvalent reported positive pivotal results for neladalkib in TKI pre-treated patients which demonstrated durable activity and a generally well-tolerated safety profile. Neladalkib is also being evaluated in an ongoing Phase...

Institutional Investment Accelerates Company’s Push to Become the First End-to-End U.S. Natural Flake Graphite Producer in 70 Years Not for distribution to U.S. news wire services or dissemination in the United States. GOUVERNEUR, N.Y., Dec. 16, 2025 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX:TI, NYSE-A:TII), (“Titan” or the “Company”) an existing zinc concentrate producer in upstate New York and an emerging natural flake graphite producer (a key component of the broader rare earths and critical minerals ecosystem), announced today a US$15 million investment from a leading institutional equity investor, strengthening the Company’s balance sheet and accelerating development of its Kilbourne Graphite Project (“Kilbourne”) in New York State. The investment, together with the previously announced US$5.5 million U.S. EXIM Bank...

GOUVERNEUR, N.Y., Dec. 16, 2025 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX:TI, NYSE-A:TII), (“Titan” or the “Company”) an existing zinc concentrate producer in upstate New York and an emerging natural flake graphite producer (a key component of the broader rare earths and critical minerals ecosystem), announced today a US$15 million investment from a leading institutional equity investor, strengthening the Company’s balance sheet and accelerating development of its Kilbourne Graphite Project (“Kilbourne”) in New York State. The investment, together with the previously announced US$5.5 million U.S. EXIM Bank support, positions Titan to fast-track completion of the Kilbourne Graphite Feasibility Study in 2026 and advance the project toward construction. The investment will be completed through a private placement of 6,666,666...